Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Short-Term Debt issuances (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Short-Term Debt issuances over the past 12 years, most recently at -$6.0 million for Q1 2025.

  • For Q1 2025, Short-Term Debt issuances fell 297.69% year-over-year to -$6.0 million; the TTM value through Feb 2025 reached $129.3 million, up 120.81%, while the annual FY2024 figure was $149.6 million, 375.63% up from the prior year.
  • Short-Term Debt issuances for Q1 2025 was -$6.0 million at Lifecore Biomedical, Inc. \De\, up from -$13.1 million in the prior quarter.
  • Over five years, Short-Term Debt issuances peaked at $146.5 million in Q2 2024 and troughed at -$32.0 million in Q1 2023.
  • A 5-year average of $17.4 million and a median of $4.0 million in 2022 define the central range for Short-Term Debt issuances.
  • Biggest five-year swings in Short-Term Debt issuances: skyrocketed 449.01% in 2023 and later crashed 492.45% in 2024.
  • Year by year, Short-Term Debt issuances stood at $18.0 million in 2021, then plummeted by 77.78% to $4.0 million in 2022, then tumbled by 155.3% to -$2.2 million in 2023, then crashed by 492.45% to -$13.1 million in 2024, then surged by 54.22% to -$6.0 million in 2025.
  • Business Quant data shows Short-Term Debt issuances for LFCR at -$6.0 million in Q1 2025, -$13.1 million in Q4 2024, and $1.9 million in Q3 2024.